CMIC Group Overview, as of December 2023. Corporate Overview History […]
The first and largest CRO in Japan offers you services […]
Your Strategic Partner for Expert Drug Development and Manufacturing Fully […]
We sincerely appreciate your support during our 30 year journey! […]
This is the article originally published in Newsweek on November […]
C-CAST is a mini-video series presented by CMIC Group. As […]
Since its introduction in the 1980s, the market of orally […]
The COVID-19 global pandemic took the world by storm, disrupting […]
Virtual pharmaceutical companies often have strong regulatory and clinical teams, […]
Executive interview with CMIC CDMO CEO, Makoto Matsukawa Interview Includes: […]
Learn more about CMIC Group’s parenteral drug manufacturing building of […]
Your Strategic Partner for Expert Drug Development and Manufacturing As […]
Development and Manufacturing: Insights into the Precision Medicine Model Download […]
CMIC was founded in 1992 as the first contract research […]
April 2020, Pharmaceutical Technology Download this eBook to learn more […]
Your Strategic Partner for Expert Drug Development and Manufacturing Bridging […]
Contract manufacturers are right at the center of the transformation that is reshaping the pharmaceutical and biotech industry. Their central position brings opportunities and challenges that keep them striving to stay on top of quality, technological innovation and safety and regulatory considerations. The flip side of this is working strategically to ensure the right business decisions are made, managing costs and astutely investing in technology.
Since its introduction in the 1980s, the market of orally disintegrating tablet (ODT) has grown annually and ODTs are now available in a variety of therapeutic areas, both over-the-counter (OTC) and by prescription. ODT market is projected to reach US$21B in 2023. In this webinar, CMIC and Aprecia experts talked about advanced ODT technologies and its advantages in drug development.
